Johnson & Johnson (JNJ) P/E (2009 - 2026)
Johnson & Johnson (JNJ) P/E from Jun 29, 2009 to Jul 20, 2026. The TTM Johnson & Johnson (JNJ) P/E is 22.26. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Johnson & Johnson (JNJ)
| Year | P/E | Change |
|---|---|---|
| 2026 | 22.26 | +8.95% |
| 2025 | 20.43 | +108.17% |
| 2024 | 9.82 | -12.54% |
| 2023 | 11.22 | -56.30% |
| 2022 | 25.68 | +12.33% |
| 2021 | 22.86 | -18.75% |
| 2020 | 28.14 | +9.07% |
| 2019 | 25.80 | +19.36% |
| 2018 | 21.61 | -6.85% |
| 2017 | 23.20 | +16.60% |
| 2016 | 19.90 | +17.82% |
| 2015 | 16.89 | -3.93% |
| 2014 | 17.58 | -8.79% |
| 2013 | 19.27 | +15.13% |
| 2012 | 16.74 | +19.83% |
| 2011 | 13.97 | +20.83% |
| 2010 | 11.56 | -57.32% |
| 2009 | 27.09 | N/A |
Comparison Johnson & Johnson (JNJ) P/E with competitors
Johnson & Johnson (JNJ) P/E is 22.26.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -54.59% |
| PFE | Pfizer Inc | 11.65 | -47.65% |
| NVO | Novo Nordisk | 11.79 | -47.03% |
| GSK | GSK Plc | 12.10 | -45.63% |
| SNY | Sanofi | 12.12 | -45.53% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -37.92% |
| OGN | Organon & Company | 14.33 | -35.64% |
| BIIB | Biogen Inc | 17.41 | -21.81% |
| GILD | Gilead Sciences Inc | 17.75 | -20.28% |
| NVS | Novartis AG | 21.60 | -2.98% |
| AMGN | AMGEN Inc | 24.75 | +11.19% |
| MRK | Merck & Co Inc | 26.93 | +20.96% |
| AZN | Astrazeneca plc | 28.44 | +27.77% |
| LLY | Lilly(Eli) & Company | 48.44 | +117.62% |
| ABBV | Abbvie Inc | 139.08 | +524.79% |